{"id":59475,"date":"2024-09-15T12:04:43","date_gmt":"2024-09-15T12:04:43","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/09\/15\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/"},"modified":"2024-09-15T12:04:43","modified_gmt":"2024-09-15T12:04:43","slug":"precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/","title":{"rendered":"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging"},"content":{"rendered":"<div>\n<ul>\n<li><em>Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development\u00a0<\/em><\/li>\n<li><em>Quantitative PSMA-PET imaging is required to determine patient eligibility for the first FDA-approved PSMA-targeting medicine and is an inclusion criterion for ongoing trials<\/em><\/li>\n<\/ul>\n<p align=\"justify\">BOSTON, Sept.  15, 2024  (GLOBE NEWSWIRE) &#8212; Precede Biosciences, a company impacting the development and use of precision medicines with a first-in-class comprehensive epigenomic liquid biopsy platform, today shared the company\u2019s scientific poster presentation from the 2024 European Society for Medical Oncology (ESMO) Annual Meeting taking place from September 13 to 17, 2024 in Barcelona, Spain.<\/p>\n<p align=\"justify\">\u201cThese data highlight the ability for comprehensive epigenomic profiling to deliver a minimally invasive and clinically accessible surrogate of tumor PSMA expression in men with metastatic castration-resistant prostate cancer,\u201d said Jacob E. Berchuck, MD, Assistant Professor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University. \u201cGiven PSMA-PET is not equally accessible across the USA and across the globe, assessment of PSMA tumor expression from blood could enable optimized patient identification for the one approved and the many emerging medicines targeting PSMA.\u201d<\/p>\n<p align=\"justify\">\u201cThese promising data highlight the potential of the Precede Bio platform to resolve important actionable targets from a simple blood draw,\u201d said Carl Barrett, Chief Scientific Officer of Precede Bio. \u201cPSMA is the number one target for the next wave of precision medicines in prostate cancer, and these data support the promise of our platform to inform on therapy selection in this context. We look forward to continuing to work with leading academics and drug developers to advance this important work, and at the same time to continue our work on other high-value targets, such as DLL3 and STEAP1, all with the goal of informing therapy selection for medicines against these targets from the same 1 mL of plasma.\u201d<\/p>\n<p align=\"justify\">Data presented at the 2024 ESMO Annual Meeting can be found in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=55y15iavbD-EdvKz_cC1C_4EDDOT14XI7pBIvjDXtypPkiUhlzcO646oY2QOTnD9_r0oPPEjyKZbHhEhe8Y3Bh2t1q_sTuPE639zJG_uu00=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"presentations\">presentations<\/a> section of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nXiLVWdhHNSMOQlVR67tO5ODfyQ8-BvATNx5LQAQ-QA58Zr8gtPfhb3BqaN3NcmnpX2N-qxhFbdGvIuowCrgfw==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"company website\">company website<\/a> and below:<\/p>\n<p align=\"justify\"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MJVepIYZ5O90LhOkGpIuOXcawtLb70oPT2H9IQuUjK93hVoFVVAky46cxjLPA1bX4gn_l2fZKtDqiEu7Ly3yDfH0M38OrsR34sGzAIKBNa2Rv0RoCzxEk6ac-TeIxwkiV-ykFXpCe01XwzMOLTfrpY3MqmIcQuo0o_UrOAFw47zjc-LhiFg4ontgq6QAdpYOLAiI0q7NMmglItSSNXbbR3K6u8hvz6E-lVkMyUjvxfm4UkuFcA_bhQfvxGA-RJDGnLe0znHw-ZL_p12etO12w388gNaXZko8f3ZsjP7z0EtIZC5s9GEc7G5-MqtBPI1N-TFmWm4IYpxGl5UX4ubMr7W7trwqYzhOlqG98fRiEuU=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Determination of tumor PSMA expression in prostate cancer from blood using a novel epigenomic liquid biopsy platform\">Determination of tumor PSMA expression in prostate cancer from blood using a novel epigenomic liquid biopsy platform<\/a><\/p>\n<p><strong>About Precede Biosciences<\/strong>&#x200d;<\/p>\n<p align=\"justify\">Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be learned from a simple blood draw. By understanding the fundamental biology behind disease at any given moment, researchers and clinicians can better target medicines to the right patients in both drug development and clinical practice. Precede Bio seeks to improve success rates in drug development and to be a part of building a future where every patient can receive a rapid, minimally invasive diagnosis and therapy that is precise to the biology of their disease. Precede Bio\u2019s platform is available to drug developers and academic researchers. To learn more, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1hO3lBMeDRez-10QPv0f4PqUS9gxReYkBmIU5rF8XMEhgywXmWTPqWZ4GQei03y2G2ETiOyCv0homBvXsX458w==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>www.precede.bio<\/u><\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zP3KtmOCIGqx7tHGf1PDpXTYO1odQJPQoW7Fa-Ne1NAwLt3LQIDk3jaELD9E7Fs898esSWPZeHGHMMHkWUOM6Q==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>X\/Twitter<\/u><\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oW-QYIBrv318DYXJL-FKFLgrNusaIYAvSINTaHfJ7QgloLZsfoDwTf1trHpQ6QadHsIQIygcVxv2UXPPR2U4_AY3AjHusQ1pEg-tdFaUn4RbX36sS4hQUZuHLj021EMn\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>LinkedIn<\/u><\/a>.\u00a0<strong>&#x200d;<\/strong><\/p>\n<p><strong>Media Contacts:<\/strong>&#x200d;<br \/>&#x200d;<br \/>Donelle M Gregory<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zd8aYP7vE6WkUTv39U-Dz-7EGK9-jEkW0os18E-F32LuevOMMykbtWBKaFM8icYoy2ICJepb3U5EHdduIDJKA3HOSzU7_4hJ6SDsNZm1eK4=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"media@precede.bio\">media@precede.bio<\/a><\/p>\n<p>Adam Silverstein<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ng0v4IstX-jcdWXtM44DqJBKChqWrWCtW0q3wN2wkfmHdMzOHZyHMExlwhoGWgk-vRlLXhf3ZAgndhUotnhq72L0rfDpWu3_5ukpxdevt2I=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>&#x200d;<\/u><br \/><u> adam@scientpr.com<\/u><\/a><\/u><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Njc2NWQ1NjYtNDYyOC00NTkyLTgxODItYjU1NDcxMzYyMjU2LTEyNzQ4Njc=\/tiny\/Precede-Biosciences-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development\u00a0 Quantitative PSMA-PET imaging is required to determine patient eligibility for the first FDA-approved PSMA-targeting medicine and is an inclusion criterion for ongoing trials BOSTON, Sept. 15, 2024 (GLOBE NEWSWIRE) &#8212; Precede Biosciences, a [&#8230;]\n","protected":false},"author":1,"featured_media":59476,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-59475","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging\" \/>\n<meta property=\"og:description\" content=\"Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 med\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-15T12:04:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/09\/Precede-Biosciences-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging\",\"datePublished\":\"2024-09-15T12:04:43+00:00\",\"dateModified\":\"2024-09-15T12:04:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\"},\"wordCount\":503,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\",\"name\":\"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-09-15T12:04:43+00:00\",\"dateModified\":\"2024-09-15T12:04:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/","og_locale":"en_US","og_type":"article","og_title":"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging","og_description":"Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 med","og_url":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-09-15T12:04:43+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/09\/Precede-Biosciences-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging","datePublished":"2024-09-15T12:04:43+00:00","dateModified":"2024-09-15T12:04:43+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/"},"wordCount":503,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/","url":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/","name":"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-09-15T12:04:43+00:00","dateModified":"2024-09-15T12:04:43+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/precede-biosciences-presents-new-data-at-esmo-2024-demonstrating-ability-to-reveal-tumor-psma-expression-from-a-simple-blood-test-that-is-highly-correlated-with-psma-pet-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/59475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=59475"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/59475\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/59476"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=59475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=59475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=59475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}